Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000202933 | SCV000051977 | benign | not specified | 2015-06-23 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000202933 | SCV000258079 | benign | not specified | 2015-09-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000206303 | SCV000262473 | benign | Alstrom syndrome | 2015-11-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000202933 | SCV000312406 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000202933 | SCV000344215 | likely benign | not specified | 2016-08-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000206303 | SCV000431897 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000206303 | SCV000431899 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000206303 | SCV000431900 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000206303 | SCV000431901 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000206303 | SCV000431902 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573683 | SCV001872555 | benign | not provided | 2016-10-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372192 | SCV002673412 | benign | Cardiovascular phenotype | 2018-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV000206303 | SCV000734227 | benign | Alstrom syndrome | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573683 | SCV001799920 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000202933 | SCV001930009 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000202933 | SCV001958744 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000202933 | SCV001970250 | benign | not specified | no assertion criteria provided | clinical testing |